What to Expect When Medicare and Pharma Finally Negotiate Drug Prices

Last fall, the federal government named its first 10 targets for historic drug price negotiations with big pharma. Those negotiations are expected to heat up this February when federal officials make their opening price offers.

This week, we offer a refresher on how this negotiation process will work and the impact it could have.


Anton Avanceña, PhD, Assistant Professor of Health Outcomes, University of Texas 

Darius Lakdawalla, PhD, Professor of Pharmaceutical Economics and Public Policy, University of Southern California 

Lauren Neves, JD, Deputy Vice President, PhRMA

Steve Pearson, MD, MSc, Founder and President, Institute for Clinical and Economic Review (ICER)

Ben Rome, MD, MPH, physician and researcher, Harvard Medical School

Meena Seshamani, MD, PhD, Deputy Administrator, Centers for Medicare and Medicaid Services

Leslie Walker, Senior Producer/Reporter, Tradeoffs

Learn more and read a full transcript on our website.

Support this type of journalism today, with a gift.

Hosted on Acast. See acast.com/privacy for more information.